Cara M Cannon

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile(More)
  • 1